Oral Cannabidiol for Tobacco Cessation

NCT05445804 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Use
Tobacco Smoking
Tobacco Dependence
Tobacco Use Disorder
Tobacco Use Cessation

Interventions

DRUG: 300 mg Cannabidiol
DRUG: 600 mg Cannabidiol
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]